2-Amino-6-(chloromethyl)pteridin-4(3H)-one (hydrochloride), 250mg

trans-Cinnamic Acid Zone Refined (number of passes:40)>99.8%(GC)1sample

5-(4-(tert-Butoxycarbonyl)piperazin-1-yl)pyrazine-2-carboxylic acid, 95.0%, 250mg

4-Methyl-pyridine-3,5-dicarboxylic acid dimethyl ester, 98%, 100mg

[S(R)]-N-[(R)-3,5-Bis(trifluoromethyl)phenyl][2-(dicyclohexylphosphanyl)phenyl]-N,2-dimethyl-2-propanesulfinamide, 95%, 25mg

3,5-Diaminobenzoic Acid>98.0%(HPLC)(T)500g

1-Cyclopropyl-5-(trifluoromethyl)-1h-1,2,3-triazole-4-carboxylic acid, 97%, 250mg

4,4'-[(Perfluorocyclobutane-1,2-diyl)bis(oxy)]dibenzoic acid, 1g

Fmoc-PNA-A(Bhoc)-OH, 95%, 100mg

1H-Pyrazolo[3,4-b]pyridin-3(2H)-one, 95.0%, 100mg

1-Chloro-2-fluoro-5-methyl-3-nitrobenzene, 98%, 25g

(S)-1-(3-(Difluoromethyl)-2-fluorophenyl)ethanamine hydrochloride, 97%, 1g

1-Phenyl-1-cyclopentanecarboxylic Acid>98.0%(GC)(T)5g